MNOV
MNOV
Medicinova, Inc.
1.74 USD
0.00 (-0.11%)
Last updated Oct 30, 1:30 PM
Yesterday High
$1.76
Yesterday Low
$1.66
52w High
$2.10
52w Low
$1.13
Market Cap.
$85.3M
52w Change
-7.45%
This is a preview of the full version of Prosperse
Trending News
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Sym...
MediciNova announced that an abstract regarding a clinical trial of MN-166 (ibudilast) in the treatment of Amyotrophic Lateral Sclerosis (ALS) has been selected for a poster presentation at the 35th International Symposium on ALS / MND.
Medicinova, Inc.
Sep 9, 2024
MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (North...
MediciNova announced that an abstract regarding its MN-166 (ibudilast) drug in the COMBAT-ALS Phase 2b/3 clinical trial has been accepted for presentation at the 2024 Annual NEALS Meeting.
N/A
Sep 3, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
US Stocks End Week Positively with Boost from Tech Sector and Solid Consumer Sentiment
Date: Oct 25, 2024
TSMC Achieves Higher Production Yields in Arizona Facility Compared to Taiwan
Date: Oct 25, 2024
Federal Judge Blocks Tapestry's $8.5 Billion Acquisition of Capri Holdings Due to Antitrust Concerns
Date: Oct 25, 2024
2024 Presidential Race Deadlock: Trump and Harris Tied in Pivotal Swing States
Date: Oct 24, 2024
Stocks Rebound as Tesla Leads Surge; UPS Gains Highlight Economic Trends
Date: Oct 24, 2024